Melissa M Ross, Sarah Mulnick, Kristina S Boye, Jennifer Glass, Christine Longuet, Ashley Samuelson, Vivian Thuyanh Thieu, Michael Vallis, Meredith M Hoog
{"title":"The Value and Impact of Weight Reduction from the Perspective of People in Canada with Type 2 Diabetes.","authors":"Melissa M Ross, Sarah Mulnick, Kristina S Boye, Jennifer Glass, Christine Longuet, Ashley Samuelson, Vivian Thuyanh Thieu, Michael Vallis, Meredith M Hoog","doi":"10.1007/s12325-026-03581-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Obesity and overweight are major contributing factors for type 2 diabetes (T2D). Here, we explored the perspectives of people with T2D on the value and expected impacts of reaching a lower weight.</p><p><strong>Methods: </strong>Adult residents of Canada with T2D completed a cross-sectional survey informed by qualitative interviews. Survey questions explored weight management experiences, T2D and weight impacts on quality of life, and the value of losing 5%, 10%, or 20% body weight. Results were summarized descriptively.</p><p><strong>Results: </strong>Of 358 participants, 56% were male and 81% were white, with a mean age of 59 years (SD 13) and a mean self-reported body mass index of 32.9 kg/m<sup>2</sup> (SD 7.9); 44% of participants had a current hemoglobin A1C < 7%. T2D negatively affected quality of life, particularly impacting emotional well-being (50%), other illnesses (48%), and sleep (49%). Most participants believed their weight affected their T2D (85%), felt they needed to lose weight (89%), struggled to lose weight (79%), and deemed weight management to be crucial for T2D management (94%). Participants' average \"dream\" weight loss was a 19% reduction. Most participants anticipated losing 5%, 10%, or 20% body weight would significantly improve their future with T2D (64%, 75%, or 71%) and overall health (79%, 85%, and 90%), and would have a positive impact (70%, 78%, or 71%), particularly on appearance, comorbidities, and emotional well-being.</p><p><strong>Conclusion: </strong>Participants with T2D valued weight loss and anticipated improvements to their health and quality of life with greater perceived value and impacts associated with increased weight reductions.</p>","PeriodicalId":7482,"journal":{"name":"Advances in Therapy","volume":" ","pages":""},"PeriodicalIF":4.0000,"publicationDate":"2026-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12325-026-03581-9","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Obesity and overweight are major contributing factors for type 2 diabetes (T2D). Here, we explored the perspectives of people with T2D on the value and expected impacts of reaching a lower weight.
Methods: Adult residents of Canada with T2D completed a cross-sectional survey informed by qualitative interviews. Survey questions explored weight management experiences, T2D and weight impacts on quality of life, and the value of losing 5%, 10%, or 20% body weight. Results were summarized descriptively.
Results: Of 358 participants, 56% were male and 81% were white, with a mean age of 59 years (SD 13) and a mean self-reported body mass index of 32.9 kg/m2 (SD 7.9); 44% of participants had a current hemoglobin A1C < 7%. T2D negatively affected quality of life, particularly impacting emotional well-being (50%), other illnesses (48%), and sleep (49%). Most participants believed their weight affected their T2D (85%), felt they needed to lose weight (89%), struggled to lose weight (79%), and deemed weight management to be crucial for T2D management (94%). Participants' average "dream" weight loss was a 19% reduction. Most participants anticipated losing 5%, 10%, or 20% body weight would significantly improve their future with T2D (64%, 75%, or 71%) and overall health (79%, 85%, and 90%), and would have a positive impact (70%, 78%, or 71%), particularly on appearance, comorbidities, and emotional well-being.
Conclusion: Participants with T2D valued weight loss and anticipated improvements to their health and quality of life with greater perceived value and impacts associated with increased weight reductions.
期刊介绍:
Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.
The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.